APA (7th ed.) Citation

Huang, R., Zheng, Y., Zou, W., Liu, C., Liu, J., & Yue, J. (2022). Blood Biomarkers Predict Survival Outcomes in Patients with Hepatitis B Virus-Induced Hepatocellular Carcinoma Treated with PD-1 Inhibitors. Journal of Immunology Research, 2022, . https://doi.org/10.1155/2022/3781109

Chicago Style (17th ed.) Citation

Huang, Rui, Yanfen Zheng, Wenxue Zou, Chao Liu, Jibing Liu, and Jinbo Yue. "Blood Biomarkers Predict Survival Outcomes in Patients with Hepatitis B Virus-Induced Hepatocellular Carcinoma Treated with PD-1 Inhibitors." Journal of Immunology Research 2022 (2022). https://doi.org/10.1155/2022/3781109.

MLA (9th ed.) Citation

Huang, Rui, et al. "Blood Biomarkers Predict Survival Outcomes in Patients with Hepatitis B Virus-Induced Hepatocellular Carcinoma Treated with PD-1 Inhibitors." Journal of Immunology Research, vol. 2022, 2022, https://doi.org/10.1155/2022/3781109.